|
Delayed
Nasdaq Stockholm
05:56:16 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 3.450 SEK | +1.47% |
|
+24.10% | +134.69% |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Biotechnology | 35.03M | 83K | 51.69M | 66.14M | 167M | |||||
Total Assets | 79.14M | 37.42M | 62.38M | 42.06M | 137M | |||||
Interest Expense | -269K | -1K | - | -40K | -424K | |||||
CAPEX | -2.71M | - | -2.45M | -1.3M | -94K | |||||
EBT | -25.08M | -60.17M | -438K | -18.28M | 91.74M | |||||
D&A | 590K | 618K | 447K | 958K | 1.07M | |||||
Operating Income | -25.63M | -60.74M | -845K | -19.67M | 97.29M | |||||
Net Income | -25.08M | -60.17M | -438K | -18.28M | 91.74M |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
USA | 35.11M | 35K | 50.44M | 65.62M | 167M | |||||
Sweden | - | 48K | 41K | 16K | 6K | |||||
Operating Income | - | - | - | - | - | |||||
| - | - | - | - | 167M | ||||||
Asia | - | - | - | - | - | |||||
Europe | - | - | - | - | - | |||||
| - | - | - | - | 6K |
- Stock Market
- Stocks
- SPRINT Stock
- Financials Sprint Bioscience AB
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
